The global flow cytometry market size is expected to reach USD 7,531.2 million by 2030, registering a CAGR of 7.17% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.
Flow Cytometry Market Report Highlights
- The instrument product segment held the largest share in 2022 due to technical advancements, as well as increased prevalence of chronic conditions
- Thecell-based flow cytometry technology dominated the industry in 2022 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
- By application, the clinical segment accounted for the largest revenue share in 2022 owing to increased activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
- The academic institutes end-user segment led the market in 2022 owing to increased R&D activities by academic institutes & research centers
- North America was the leading region in 2022 due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
- Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India
Gain deeper insights on the market and receive your free copy with TOC now @: Flow Cytometry Market Report
Flow cytometry is a technology that is used to detect and measure physical and chemical characteristics of a population of cells or particles as they flow past single or multiple lasers while suspended in a buffered solution and used for qualitative and quantitative measurement of biological and physical properties of cells. The light produced by lasers is scattered by cells in the sample, measured by detectors, and then translated to signals that can be analyzed and measured. They consist of three main systems: fluidics, optics, & electronics, and are used in immunology, virology, molecular biology, cancer biology, and infectious disease monitoring.
Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.
Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk–TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.
It helps analyze patients’ need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.
On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost–under USD 100,000–in the near future.
Flow Cytometry Market Insights By Region
North America dominated the overall market. This dominance is due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the U.S. The high prevalence of infectious and chronic diseases, including the outbreak of COVID-19, has led to an increase in the demand for the technique for research and diagnosis purposes. Asia Pacific is anticipated to witness a significant growth as a result of the growing pharmaceutical and biotechnology industries in emerging economies, such as China and India. The industry is driven by the growing incidence of chronic diseases and the increasing use of cytometry devices in various applications in the region. Ongoing innovations in the fields of cancer & infectious illnesses, such as COVID-19, are expected to drive the regional market.
Competitive Analysis By Major Companies
Key players in the industry are implementing various strategies including new product launches investments, strategic collaborations, geographical expansions, and partnerships through mergers & acquisitions to expand their market presence. Some of the prominent key players in the global flow cytometry market include Danaher Corp.; Becton, Dickinson, and Company (BD); Sysmex Corp.; Agilent Technologies, Inc.; Apogee Flow Systems Ltd.; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.
For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/flow-cytometry-market/request/rs5
Flow Cytometry Market Segmentation
Grand View Research has segmented the global flow cytometry market based on product, technology, application, end-use, and region:
- Flow Cytometry Product Outlook (Revenue, USD Million, 2018 – 2030)
- Flow Cytometry Technology Outlook (Revenue, USD Million, 2018 – 2030)
- Flow Cytometry Application Outlook (Revenue, USD Million, 2018 – 2030)
- Flow Cytometry End-use Outlook (Revenue, USD Million, 2018 – 2030)
- Flow Cytometry Regional Outlook (Revenue, USD Million, 2018 – 2030)
- List of Key Players of Flow Cytometry Market
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/special-pricing/1805/rfsp2
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com